BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1301 related articles for article (PubMed ID: 15356140)

  • 1. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.
    Olson JK; Miller SD
    J Immunol; 2004 Sep; 173(6):3916-24. PubMed ID: 15356140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells.
    Matsushima H; Yamada N; Matsue H; Shimada S
    J Immunol; 2004 Jul; 173(1):531-41. PubMed ID: 15210814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
    Nishiya T; DeFranco AL
    J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad expression of Toll-like receptors in the human central nervous system.
    Bsibsi M; Ravid R; Gveric D; van Noort JM
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):1013-21. PubMed ID: 12430718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease.
    Duncan DS; Miller SD
    PLoS One; 2011 Apr; 6(4):e18548. PubMed ID: 21494618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus.
    Olson JK; Girvin AM; Miller SD
    J Virol; 2001 Oct; 75(20):9780-9. PubMed ID: 11559811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.
    Nagase H; Okugawa S; Ota Y; Yamaguchi M; Tomizawa H; Matsushima K; Ohta K; Yamamoto K; Hirai K
    J Immunol; 2003 Oct; 171(8):3977-82. PubMed ID: 14530316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression and function of Toll-like receptor 3 in human astrocytes.
    Farina C; Krumbholz M; Giese T; Hartmann G; Aloisi F; Meinl E
    J Neuroimmunol; 2005 Feb; 159(1-2):12-9. PubMed ID: 15652398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression.
    Kielian T; Mayes P; Kielian M
    J Neuroimmunol; 2002 Sep; 130(1-2):86-99. PubMed ID: 12225891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis.
    Mack CL; Vanderlugt-Castaneda CL; Neville KL; Miller SD
    J Neuroimmunol; 2003 Nov; 144(1-2):68-79. PubMed ID: 14597100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.
    Schaefer TM; Desouza K; Fahey JV; Beagley KW; Wira CR
    Immunology; 2004 Jul; 112(3):428-36. PubMed ID: 15196211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling danger: toll-like receptors and their potential roles in kidney disease.
    Anders HJ; Banas B; Schlöndorff D
    J Am Soc Nephrol; 2004 Apr; 15(4):854-67. PubMed ID: 15034087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
    Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
    Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors as adjuvant receptors.
    Kaisho T; Akira S
    Biochim Biophys Acta; 2002 Feb; 1589(1):1-13. PubMed ID: 11909637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
    Sirén J; Pirhonen J; Julkunen I; Matikainen S
    J Immunol; 2005 Feb; 174(4):1932-7. PubMed ID: 15699120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
    Derkow K; Krüger C; Dembny P; Lehnardt S
    PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication.
    Equils O; Schito ML; Karahashi H; Madak Z; Yarali A; Michelsen KS; Sher A; Arditi M
    J Immunol; 2003 May; 170(10):5159-64. PubMed ID: 12734363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages.
    Sweet MJ; Campbell CC; Sester DP; Xu D; McDonald RC; Stacey KJ; Hume DA; Liew FY
    J Immunol; 2002 Jan; 168(1):392-9. PubMed ID: 11751985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: impaired Toll-like receptor expression and function in aging.
    Renshaw M; Rockwell J; Engleman C; Gewirtz A; Katz J; Sambhara S
    J Immunol; 2002 Nov; 169(9):4697-701. PubMed ID: 12391175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
    Gelman AE; Zhang J; Choi Y; Turka LA
    J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.